arrow
返回

Utilization management in microbiology

delete2014-01-01
delete3
delete
OA
AI
J
John A. Branda
K
Kent Lewandrowski *
DOI:10.1016/j.cca.2013.09.031delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
The available literature concerning utilization management in the clinical microbiology laboratory is relatively limited compared with that for high-volume, automated testing in the central Core Laboratory. However, the same strategies employed elsewhere in the clinical laboratory operation can be applied to utilization management challenges in microbiology, including decision support systems, application of evidence-based medicine, screening algorithms and gatekeeper functions. The results of testing in the microbiology laboratory have significant effects on the cost of clinical care, especially costs related to antimicrobial agents and infection control practices. Consequently many of the successful utilization management interventions described in clinical microbiology have targeted not just the volume of tests performed in the laboratory, but also the downstream costs of care. This article will review utilization management strategies in clinical microbiology, including specific examples from our institution and other healthcare organizations. (C) 2013 Elsevier B.V. All rights reserved.
Keyword:
Utilization management
Microbiology
Antimicrobial stewardship
Decision support
MALDI-TOF mass spectroscopy
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Clinica Chimica Acta 封面图
Clinica Chimica Acta
IF:
2.9
论文数:
1.6W
被引数:
2.1W

机构

H
Harvard University
学者数:
26.5W
论文数: 22.0W
被引数: 28.7W
引用论文

引用论文

err分享
err收藏
err分享
err收藏
Does NT‐proBNP Remain a Sensitive Biomarker for Chronic Heart Failure after Administration of a Beta‐blocker?
err2007-09-05
err0
errOAAI
errNa Li; Yishi Li; Fang Wang; Wen Jiang; Jie Huang; Zhimin Xu; Lu Hua; Congxiao Hua; Yan Huang; Ying Wu; Feiou Li
err分享
err收藏
学者 查看更多内容